Scientists Advancing Affordable Medicines Inc
Nonprofit profile at a glance
- EIN
- 825103616
- IRS 990-EZ coverage
- 2018–2024
- Forms available
- Form 990-EZ 2024
- Location
- Englewood, NJ, USA
- Phone
- 9737440160
- Rating
- 75
- Verdict
- SUPPORTED
- Rating confidence
- Moderate
- Sector
- Chambers of Commerce & Business Leagues
Reported finances
- Revenue
- $9,300
- Expenses
- $18,940
- Assets
- $20,961
- Liabilities
- $0
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Amounts in USD.
Leadership & pay
9 people listed
Executive titles in this filing
- KEITH GALLICANO (PRESIDENT)
People named in this filing
- SUSANA ALMEIDA (TRUSTEE)
- ANNA SCHWENDEMAN (TRUSTEE)
- PRADEEP BHADAURIA (TRUSTEE)
Selected names, not a complete roster or a statement of current roles. Open leadership details for the complete filed list.
Source: IRS Form 990-EZ. Selected filing: tax year 2024. Names and roles reflect this filing, not necessarily current officeholders.
Overview
Mission
Scientists advancing affordable medicines, inc. (operating under the saamnow tradename) is a 501(c)(6) nonprofit trade organization that seeks to provide a dedicated platform for scientists to share cutting-edge research that facilitates the development of high-quality, affordable medicines, thereby improving their accessibility to patients. The organization will accomplish this by soliciting input from a broad group of pharmaceutical stakeholders including, but not limited to those involved in manufacturing, packaging, testing, research & development, supplying material and equipment, providing services, academia, regulatory science, and government agencies such as the fda and ema.
What it reported doing in 2024
Annual workshop that will be of interest to, and attended by, various affordable medicine stakeholders.
Operating model
- Revenue model
- Donor-supported. 97% of the money available for current operations came from contributions and gifts.
- Distribution model
- Direct operator. The filing allocates 100% of reported program-service expenses outside its grant, affiliate-payment, and member-benefit lines. This expense classification does not rule out separately announced grant awards.
The verdict
SUPPORTED - A large share of available resources goes toward mission work and the filed numbers largely add up. A relatively small share of total spending goes to programs and expenses are high relative to revenue.
Rating breakdown
- Financial Efficiency: 81
- Transparency & Controls: 82
- Sustainability: 32
- Growth: 0
Detailed rating inputs
Financial Efficiency
- Mission deployment rate: 99.9%; rating input score 100
- Program expense ratio: 49.1%; rating input score 49
Transparency & Controls
- Consistency checks: 100%; rating input score 100; 52nd percentile among comparable filings
- Major donor itemization: Limited
Sustainability
- Operating margin: -103.7%; rating input score 7; 7th percentile among comparable filings
- Total-asset coverage ratio: 1.11; rating input score 49; 49th percentile among comparable filings
- Liabilities to assets ratio: 0; rating input score 68; 68th percentile among comparable filings
- Officer compensation ratio: 0%; rating input score 56; 56th percentile among comparable filings
Growth
- Program expense growth: -38% per year; rating input score 0; 10th percentile among comparable filings
- Revenue growth: -40.3% per year; rating input score 0; 7th percentile among comparable filings
- Asset growth: -13.5% per year; rating input score 0; 14th percentile among comparable filings
Details
- Where the money goes: 99.9% of revenue deployed · 49.1% of spending went to programs
- Governance: Filed governance answers
- Accomplishments: 1 filed program accomplishment · $9K in reported program spending
- Leadership: top reported pay $0 · 9 people listed
- Consistency: 8 of 8 current checks pass
- Schedules: 1 filed schedules
- Filing history: 6 filing years from 2018 to 2024
- Contacts: How to reach this organization
- Grant readiness: Federal tax and exclusion status, award history, and grant-maker relationships.
- People: Everyone the filings name, and which of them the filings identify by more than a name.
Key Signals
Signals prioritize questions for review. They are not findings of misconduct.
- Moderate — Financial Efficiency: Program expense ratio scored 49/100.
- High — Sustainability: Operating margin scored 7/100.
- High — Growth: Program expense growth scored 0/100.
- High — Growth: Revenue growth scored 0/100.
- High — Growth: Asset growth scored 0/100.
- Moderate — Sustainability: Total-asset coverage ratio scored 49/100.
- Review — Sustainability: Officer compensation ratio scored 56/100.